2020
DOI: 10.1017/s0007114520001658
|View full text |Cite
|
Sign up to set email alerts
|

Effects of dietary fat quality on metabolic endotoxaemia: a systematic review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 59 publications
(179 reference statements)
0
7
0
Order By: Relevance
“…Probably, binding LPS to toll‐like receptor 4 (TLR4) resulted in production of inflammatory cytokines such as IL‐6 and interferon gamma (IFNγ) and ME 39 . Possibly CSO, as a rich plant source of OM3FA, decreases systemic inflammation and subsequently ME 40 via inhibiting the growth of Bilophila wadsworthia and increasing the growth of A. muciniphila and B ifidobacteria , decreasing postprandial lipaemia involved in chylomicron‐LPS complex transport, influencing lipids transportation through the intestinal barrier cells phospholipid membranes, increasing endogenous activity of intestinal alkaline phosphatase (ALP) involved in LPS production and intestinal permeability improvement, and inhibiting the TLR4‐induced signalling pathway through modulation of the G protein‐coupled receptor (GPR)‐120 34 . Furthermore, anti‐inflammatory effects of OM3FA may be related to the suppression of the formation of omega‐6‐derived inflammatory lipid derivatives, production of omega‐3‐derived endocannabinoids, ethanolamides and oxylipins, as well as endocannabinoid system modulation 5,41 …”
Section: Discussionmentioning
confidence: 99%
“…Probably, binding LPS to toll‐like receptor 4 (TLR4) resulted in production of inflammatory cytokines such as IL‐6 and interferon gamma (IFNγ) and ME 39 . Possibly CSO, as a rich plant source of OM3FA, decreases systemic inflammation and subsequently ME 40 via inhibiting the growth of Bilophila wadsworthia and increasing the growth of A. muciniphila and B ifidobacteria , decreasing postprandial lipaemia involved in chylomicron‐LPS complex transport, influencing lipids transportation through the intestinal barrier cells phospholipid membranes, increasing endogenous activity of intestinal alkaline phosphatase (ALP) involved in LPS production and intestinal permeability improvement, and inhibiting the TLR4‐induced signalling pathway through modulation of the G protein‐coupled receptor (GPR)‐120 34 . Furthermore, anti‐inflammatory effects of OM3FA may be related to the suppression of the formation of omega‐6‐derived inflammatory lipid derivatives, production of omega‐3‐derived endocannabinoids, ethanolamides and oxylipins, as well as endocannabinoid system modulation 5,41 …”
Section: Discussionmentioning
confidence: 99%
“…42 Possibly CSO, as a source of OM3FA decreases systemic inflammation and subsequently ME 43 via inhibiting the growth of Bilophila wadsworthia and increasing the growth of A. muciniphila and bifidobacteria, decreasing postprandial lipaemia involved in chylomicron-LPS complex transport, influencing lipids transportation through the intestinal barrier cells phospholipid membranes, increasing endogenous activity of intestinal ALP involved in LPS production and intestinal permeability improvement, and inhibiting the TLR4-induced signaling pathway through modulation of the G protein-coupled receptor (GPR)-120. 37 Furthermore, anti-inflammatory effects of OM3FA may be related to the suppression of the formation of omega-6-derived inflammatory lipid derivatives, production of omega-3-derived endocannabinoids, ethanolamides and oxylipins, as well as endocannabinoid system modulation. 5,44 In the current study, another effect of CSO in patients with NAFLD was the modulation of OS biomarkers.…”
Section: Discussionmentioning
confidence: 99%
“…Changes in dietary patterns with excessive HFD consumption may be a dominant factor required to provoke a major shift in the composition of intestinal microbiota, with changes in the composition of Bacteroidetes and Firmicutes, and leads to metabolic endotoxemia . The change in gut microbiota could result in increased LPS levels due to increased endotoxin production, and the gut microbiota is characterized by reduction in the beneficial bacteria such as Lactobacillus spp., Bifidobacterium spp., and Bacteroides-Prevotella spp. , Studies demonstrated that SFA also seem to act as a major risk factor for the transient rise in endotoxemia, associated with increasing postprandial LPS concentrations . Metabolic endotoxemia and elevated systemic LPS contribute to increased intestinal permeability .…”
Section: Gut Microbial and Dietary Influence On Metabolic Endotoxemiamentioning
confidence: 99%
“…224,225 Studies demonstrated that SFA also seem to act as a major risk factor for the transient rise in endotoxemia, associated with increasing postprandial LPS concentrations. 226 Metabolic endotoxemia and elevated systemic LPS contribute to increased intestinal permeability. 227 An elevated level of intestinal LPS can destruct the intestinal epithelial cell tight junction through the TLR4 (Toll-like receptor 4) signal transduction pathway as well.…”
Section: Metabolic Endotoxemiamentioning
confidence: 99%